TREE NEWS update: New growth drivers including high-end manufacturing, the smart economy and modern services contributed more than 40% of China’s economic growth in the first three quarters, Zuo Gang, deputy director of the NDRC’s Department of National Economic Comprehensive Affairs, said at a press conference on October 20. Outbound licensing of innovative drugs reached about $130 billion in the period, close to the full-year total for last year.
China NDRC: New growth drivers contributed over 40% to economic growth in first three quarters
The framing matters as much as the figure: by attributing over 40% of growth to "new drivers," the NDRC is signalling that policy support will keep tilting toward high-end manufacturing, the smart economy and modern services rather than traditional stimulus. The drug-licensing detail is the more concrete signal, with outbound licensing already near last year's full-year level, suggesting China's biotech pipeline is becoming an export asset rather than a domestic story. Whether that licensing pace holds through the fourth quarter, and whether the "new drivers" share is sustained rather than a compositional artifact of weak old drivers, is the open question.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.